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Integration of highly sensitive photonic biosensors and microfluidic
technologies provide new possibilities for molecular diagnostics.
Most contemporary clinical diagnostic tests are based on time-
consuming, expensive, and sophisticated techniques performed
by specialized technicians in laboratory environments. Further-
more, these techniques typically require labeling of the samples
with fluorescent or radioactive markers. Given the complexity
of these procedures, there is an urgent need for methods that
can provide fast, simple, and cost-effective analytical testing.
Advances in micro- and nanobiosensors offer the possibility of
diagnostic tools with increased sensitivity, specificity, and relia-
bility for in vivo and in vitro analytical applications. These sen-
sors also afford the possibility of taking different measurements
in parallel and integrating several analytical steps, from sample
preparation to detection, into a single miniaturized device (i.e.,
lab-on-a-chip).
Our devices are based on integrating optical label-free biosen-
sor arrays within microfluidic networks. The biosensors them-
selves rely on evanescent field principles to achieve high lev-
els of sensitivity. When an interaction between a receptor
molecule—previously immobilized on the core of the sensor (i.e.,
waveguide surface)—and its complementary analyte occurs, this
produces a change in the optical properties of the propagated
light within the waveguide via the evanescent field (see Fig-
ure 1). The highest surface sensitivity is obtained in waveguides
with a high contrast refractive index between the core and the
substrate as well as a small-dimension core thickness.
To detect changes in the optical properties of the propagated
light produced by the biosensors, we have chosen a highly sen-
sitive Mach–Zehnder interferometer (MZI) device1 constructed
from rib waveguides of nanometer dimensions: see Figure 2(b).
In this configuration, the guided light is split into two arms, and
Figure 1. Scheme representing evanescent field sensing. The biomolec-
ular interaction takes place on the waveguide surface (core) inside the
evanescent area, which influences the effective refractive index (N) of
the transmitted mode light. n: Refractive index. e: External. c: Core. s:
Substrate.
after a certain distance they are recombined again in an output
optical waveguide. In one of the arms, a sensor area houses the
specific bioreceptor. The phase shift between the two arms is
measured to determine the extent of the molecular interactions
occurring in the sensor area. To obtain single-mode behavior, the
parameters of the waveguide must be carefully chosen.
The sensor has been applied to real-time and label-free de-
tection of single DNA point mutations in the BRCA-1 gene,
which can identify women who are predisposed to develop-
ing breast cancer. The MZI-based sensor successfully discrimi-
nated between normal and mutant sequences and demonstrated
a limit of detection in the picomolar range for fully hybridized
DNA and a limit of detection in the nanomolar range for single-
point mutations.
For the lab-on-a-chip development, the sensors have been in-
tegrated with a microfluidic network at the wafer level. The mi-
croflow cells—see Figure 2(a)—consist of a three-dimensional
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Figure 2. Acrylic housing for connection to the macroworld. (a) Inte-
grated SU-8 photoresist microflow cell. (b) MZI chip.
embedded microchannel network fabricated using enhanced
CMOS-compatible SU-8 photoresist multilevel polymer tech-
nology on top of a wafer containing the MZI nanophotonic
biosensor devices. The platform can operate at pressure drops
up to 1000kPa under steady-state flow rates ranging from 1 to
1000µl/min in the laminar flow regime.2
Further development of biosensing microsystem platforms
based on the integration ofMZI, microfluidics, and optical detec-
tors will lead to significant advances in clinical diagnostics. Cur-
rently, we are developing the technology for direct fabrication of
grating couplers onto the waveguides for light diffraction and
coupling, which promises significant increases in sensitivity.3 In
the future, fabrication of nano/macrosystems with hybrid inte-
gration of light sources, photodetectors, transducers, microflu-
idics, and electronic functions will offer the possibility of diag-
nostic tools with increased sensitivity, specificity, and reliability
for early disease detection.
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